相关实验视频

Updated: Jun 21, 2025

Author Spotlight: Insight Into Advances in Prion Diseases Research
10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

458

二甲美西宁调节肠质细胞异质性以缓解结肠炎

Peishan Qiu1,2, Ying Chang1,2, Xiaoyu Chen1,2

  • 1Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|July 12, 2024
PubMed
概括

乙甲胺素 (DHA) 通过恢复肠道屏障完整性和调节肠质细胞 (EGC) 异质性来缓解结肠炎. DHA治疗可以减少炎症并改善肠道失调,为炎症性肠道疾病提供潜在的治疗策略.

关键词:
大肠炎是一种大肠炎.这是一种二甲胺氨酸.这种疾病叫做dysbiosis.肠道质细胞 肠道质细胞肠道屏障障碍物 肠道屏障障碍物现型转变变化的表型转变.

更多相关视频

Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery08:07

Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery

Published on: October 4, 2024

309
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation08:53

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

821

相关概念视频

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
134
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156